Shankha Satpathy

Shankha Satpathy, Ph.D.

Shankha Satpathy

Shankha Satpathy is a senior group leader in the Proteomics Platform at the Broad Institute of MIT and Harvard and a co-principal investigator of the Center of Excellence for High Throughput Proteogenomic Characterization, an NCI-funded effort within the CPTAC program, along with Steven Carr and Michael Gillette.

As part of the proteomics group at Broad, Satpathy is involved in several proteomics technology development areas, and also contributes to academic- and industry-partnered collaborative projects using mass spectrometry and other proteomic tools to investigate interesting biological questions with potential translational impact. His work intersects multiple disciplines and involves both basic scientists and clinicians. As part of the CPTAC effort, he leads several clinical proteomics and proteogenomic projects.

Satpathy joined the Broad Institute in September 2017 as a postdoctoral associate in the laboratory of Steven Carr. He has been a scientist since 2019, a group leader since 2020, and a senior group leader in proteomics since 2022. He conducted his doctoral research in the application of proteomics to decipher immune signaling pathways, at the Novo Nordisk Foundation Center for Protein Research in Copenhagen, and earned his Ph.D. from the University of Copenhagen in 2017. He also holds a M.S. in biochemistry and molecular biology from the Cumming School of Medicine, University of Calgary, and a B.Tech. in biotechnology from Vellore Institute of Technology, India.

As part of the Broad, he loves working in a fast-paced and collaborative environment surrounded by motivated and inspiring colleagues.

Contact Shankha Satpathy via email at

March 2023